ラクトフェリンの世界市場2020-2027:市場規模、シェア、動向分析

Grand View Researchが発行した調査報告書(GV20MY092)
◆英語タイトル:Lactoferrin Market Size, Share & Trends Analysis Report By Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial), By Application, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY092
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年4月30日
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:栄養補助食品および機能性食品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ラクトフェリンの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、機能別(鉄吸収、抗炎症、腸内フローラ保護、抗菌、免疫細胞刺激、抗酸化剤)分析、用途別(食品および飲料、乳児用調合乳、スポーツおよび機能性食品、医薬品、パーソナルケア製品、その他)分析、地域別分析、競争分析、企業概要などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・ラクトフェリンの世界市場:機能別(鉄吸収、抗炎症、腸内フローラ保護、抗菌、免疫細胞刺激、抗酸化剤)
・ラクトフェリンの世界市場:用途別(食品および飲料、乳児用調合乳、スポーツおよび機能性食品、医薬品、パーソナルケア製品、その他)
・ラクトフェリンの世界市場:地域別
・競争分析
・企業概要
【レポートの概要】

The global lactoferrin market size is projected to reach USD 379.5 million by 2027, registering a revenue-based CAGR of 8.1% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing incorporation of lactoferrin in various products ranges including infant food, food supplements, dietetic foods, alcoholic beverages, sports nutrition, and personal care and cosmetics should bolster lactoferrin market in the forecast timeframe, ascribed to strong health benefits.

Lactoferrin offers stimulating effects on immune system, prevents cell damage caused by aging, promotes culture of beneficial bacterial in the intestinal tract, and regulates viruses, bacteria and fungi along with being regulator to iron metabolism. Lactoferrin is found effective for the treatment of hepatitis C infection by inhibiting replication of the virus at intracellular level. Hence, strong applicability of lactoferrin in nutraceutical, pharmaceutical, and personal care industries is anticipated to drive demand during the forecast period.

Human colostrum has the highest lactoferrin concentration, followed by human milk and then by bovine milk. It is also readily found in human body secretions including nose, eyes, intestine, and respiratory tract. Lactoferrin can be used as a conjuncture of specific strains of friendly bacteria, together they are proven to boost immune function of the body, alert the white blood cells of the harmful microbes, and to stabilize colonies of gut friendly bacteria. Commercially, lactoferrin is commonly integrated with probiotics to achieve this.

Asia Pacific is expected to expand at a CAGR of over 7.5% during the forecast period. The lactoferrin market is projected to witness strong rise in demand, as the key market players continue adopting strategies to expand its presence in untapped economies of South East Asia. Countries including China, Japan, and Australia have experienced high awareness regarding the health benefits of lactoferrin, which is expected to bolster regional growth over the forecast period.

Further key findings from the report suggest:

• In terms of functions offered by lactoferrin, iron absorption segment accounted for the largest market share of over 29.0% in terms of revenue in 2019. This growth is expected to be supported by the growing incidences of iron deficiency and related disorders like anemia

• Lactoferrin helps in restricting growth of acne due to its antioxidant properties. It helps combat free radicals formed due to natural process of oxidation. These free radicals can damage the cells and tissues promoting inflammation and acne. Such factors are expected to drive the product demand in personal care and cosmetics

• Increasing investment in research, new product development, expansion of operation in developing nations, partnerships and collaboration with local players, and acquisition of small and medium sized players are among the major operational strategies taken up by key participants to strengthen and sustain their market positions

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
Chapter 3. Lactoferrin Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Lactoferrin Market Size & Growth Prospects, 2016 – 2027
3.3. Industry Value Chain Analysis
3.3.1. Major Raw Material Trends
3.3.2. Manufacturing Trends/Technology Trends
3.3.3. List of Key End-Users, by Region
3.4. Sales Channel Trends
3.5. Regulatory Framework
3.6. Lactoferrin Market – Market dynamics
3.6.1. Market driver Analysis
3.6.2. Market Restraint Analysis
3.6.3. Industry Challenges
3.7. Business Environment Analysis: Lactoferrin Market
3.7.1. Industry Analysis – Porter’s
3.7.1.1. Supplier Power
3.7.1.2. Buyer Power
3.7.1.3. Substitution Threat
3.7.1.4. Threat from New Entrant
3.7.1.5. Competitive Rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political Landscape
3.7.2.2. Environmental Landscape
3.7.2.3. Social Landscape
3.7.2.4. Technology Landscape
3.7.2.5. Economic Landscape
3.7.2.6. Legal Landscape
3.7.3. Major Deals & Strategic Alliances Analysis
3.7.3.1. Joint Ventures
3.7.3.2. Mergers & Acquisitions
Chapter 4. Lactoferrin Market: Function Estimates & Trend Analysis
4.1. Lactoferrin Market: Function movement analysis, 2019 & 2027
4.2. Iron Absorption
4.2.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
4.3. Anti-Inflammatory
4.3.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
4.4. Intestine Flora Protection
4.4.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
4.5. Antibacterial
4.5.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
4.6. Immune Cell Stimulation
4.6.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
4.7. Antioxidant
4.7.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
Chapter 5. Lactoferrin Market: Application Estimates & Trend Analysis
5.1. Lactoferrin Market: Application movement analysis, 2019 & 2027
5.2. Food & Beverages
5.2.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
5.3. Infant Formula
5.3.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
5.4. Sports & Functional Food
5.4.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
5.5. Pharmaceuticals
5.5.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
5.6. Personal Care Products
5.6.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
5.7. Others
5.7.1. Market estimates and forecasts, 2016 – 2027 (Tons) (USD Thousand)
Chapter 6. Lactoferrin Market: Regional Estimates & Trend Analysis
6.1. Lactoferrin Market: Regional movement analysis, 2019 & 2027
6.2. North America
6.2.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.2.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.2.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.2.4. U.S.
6.2.4.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.2.4.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.2.4.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.2.5. Canada
6.2.5.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.2.5.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.2.5.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.2.6. Mexico
6.2.6.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.2.6.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.2.6.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.3. Europe
6.3.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.3.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.3.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.3.4. Germany
6.3.4.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.3.4.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.3.4.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.3.5. U.K.
6.3.5.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.3.5.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.3.5.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.3.6. France
6.3.6.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.3.6.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.3.6.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.4. Asia Pacific
6.4.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.4.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.4.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.4.4. China
6.4.4.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.4.4.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.4.4.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.4.5. India
6.4.5.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.4.5.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.4.5.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.4.6. Japan
6.4.6.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.4.6.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.4.6.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.4.7. Australia
6.4.7.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.4.7.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.4.7.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.5. Central & South America
6.5.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.5.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.5.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.5.4. Brazil
6.5.4.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.5.4.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.5.4.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.6. Middle East & Africa
6.6.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.6.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.6.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
6.6.4. UAE
6.6.4.1. Market Estimates and Forecasts, 2016 – 2027 (Tons) (USD Thousand)
6.6.4.2. Market Estimates and Forecasts, By Function, 2016 – 2027 (Tons) (USD Thousand)
6.6.4.3. Market Estimates and Forecasts, By Application, 2016 – 2027 (Tons) (USD Thousand)
Chapter 7. Lactoferrin Market: Competitive Analysis
7.1. Key Global Players, Their Initiatives, & Their Impact on the Market
7.2. Key Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3. Vendor Landscape
7.3.1. List of key distributors & channel partners
7.3.2. Key customers
7.3.3. Company ranking, 2019
7.4. Public Companies
7.4.1. Company market position analysis
7.4.2. Company ranking, 2019
7.4.3. SWOT analysis
7.5. Private Companies
7.5.1. List of key emerging companies/technology disruptors/innovators
7.5.2. Geographical presence
7.5.3. Company market position analysis
Chapter 8. Company Profiles
8.1. Metagenics, Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Pharming Group NV
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Westland Cooperative Dairy Co., Ltd
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Synlait Milk Ltd.
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Ingredia SA
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. MP Biomedicals
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Tatura Milk Industries Ltd
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Glanbia PLC
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. APS BioGroup
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. ProHealth
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. Fonterra Cooperative Group Ltd.
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. Farbest Brands
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. InVitria
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
8.14. Milei GmbH
8.14.1. Company Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Strategic Initiatives
8.15. Ferrin-Tech LLC
8.15.1. Company Overview
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Strategic Initiatives
8.16. Bega Cheese Limited
8.16.1. Company Overview
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Strategic Initiatives
8.17. Warrnambool Cheese and Butter Company
8.17.1. Company Overview
8.17.2. Financial Performance
8.17.3. Product Benchmarking
8.17.4. Strategic Initiatives
8.18. Hoogwegt Group B.V.
8.18.1. Company Overview
8.18.2. Financial Performance
8.18.3. Product Benchmarking
8.18.4. Strategic Initiatives
8.19. Xi’an Oriherb Bio-Tech Co., Ltd.
8.19.1. Company Overview
8.19.2. Financial Performance
8.19.3. Product Benchmarking
8.19.4. Strategic Initiatives
8.20. Hefei Joye Import & Export Co., Ltd.
8.20.1. Company Overview
8.20.2. Financial Performance
8.20.3. Product Benchmarking
8.20.4. Strategic Initiatives
8.21. ND Pharma & Biotech Ltd.
8.21.1. Company Overview
8.21.2. Financial Performance
8.21.3. Product Benchmarking
8.21.4. Strategic Initiatives
8.22. FrieslandCampina
8.22.1. Company Overview
8.22.2. Financial Performance
8.22.3. Product Benchmarking
8.22.4. Strategic Initiatives
8.23. BioQuad Lifesciences
8.23.1. Company Overview
8.23.2. Financial Performance
8.23.3. Product Benchmarking
8.23.4. Strategic Initiatives
8.24. Milligans Food Group
8.24.1. Company Overview
8.24.2. Financial Performance
8.24.3. Product Benchmarking
8.24.4. Strategic Initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 North America Male Infertility market, by country, 2015 - 2027 (USD Million)
TABLE 3 North America Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 4 North America Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 5 U.S. Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 6 U.S. Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 7 Canada Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 8 Canada Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 9 Europe Male Infertility market, by country, 2015 - 2027 (USD Million)
TABLE 10 Europe Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 11 Europe Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 12 U.K. Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 13 U.K. Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 14 Germany Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 15 Germany Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 16 Asia Pacific Male Infertility market, by country, 2015 - 2027 (USD Million)
TABLE 17 Asia Pacific Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 18 Asia Pacific Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 19 Japan Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 20 Japan Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 21 China Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 22 China Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 23 Latin America Male Infertility market, by country, 2015 - 2027 (USD Million)
TABLE 24 Latin America Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 25 Latin America Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 26 Brazil Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 27 Brazil Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 28 Mexico Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 29 Mexico Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 30 MEA Male Infertility market, by country, 2015 - 2027 (USD Million)
TABLE 31 MEA Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 32 MEA Male Infertility market, by treatment, 2015 - 2027 (USD Million)
TABLE 33 South Africa Male Infertility market, by test, 2015 - 2027 (USD Million)
TABLE 34 South Africa Male Infertility market, by treatment, 2015 - 2027 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Male infertility market outlook, 2019 (USD Million)
FIG. 9 Market trends & outlook
FIG. 10 Male infertility market segmentation
FIG. 11 Penetration & growth prospect mapping
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Porter’s five forces analysis
FIG. 15 PESTEL analysis
FIG. 16 Male infertility test market share analysis, 2019 & 2027
FIG. 17 Male infertility test market: Segment dashboard
FIG. 18 DNA fragmentation technique market, 2015 - 2027 (USD Million)
FIG. 19 Oxidative stress analysis market, 2015 - 2027 (USD Million)
FIG. 20 Microscopic examination market, 2015 - 2027 (USD Million)
FIG. 21 Sperm agglutination market, 2015 - 2027 (USD Million)
FIG. 22 Computer assisted semen analysis market, 2015 - 2027 (USD Million)
FIG. 23 Sperm penetration assay market, 2015 - 2027 (USD Million)
FIG. 24 Others market, 2015 - 2027 (USD Million)
FIG. 25 Male infertility treatment market share analysis, 2019 & 2027
FIG. 26 Male infertility treatment market: Segment dashboard
FIG. 27 ART & varicocele surgery market, 2015 - 2027 (USD Million)
FIG. 28 Medication market, 2015 - 2027 (USD Million)
FIG. 29 Male infertility regional market share analysis, 2019 & 2027
FIG. 30 Male infertility regional market: Segment dashboard
FIG. 31 Regional market place: Key takeaways
FIG. 32 SWOT analysis: North America
FIG. 33 SWOT analysis: Europe
FIG. 34 SWOT analysis: Asia Pacific
FIG. 35 SWOT analysis: Latin America
FIG. 36 SWOT analysis: MEA
FIG. 37 North America male infertility market, 2015 - 2027 (USD Million)
FIG. 38 U.S. male infertility market, 2015 - 2027 (USD Million)
FIG. 39 Canada male infertility market, 2015 - 2027 (USD Million)
FIG. 40 Europe male infertility market, 2015 - 2027 (USD Million)
FIG. 41 U.K. male infertility market, 2015 - 2027 (USD Million)
FIG. 42 Germany male infertility market, 2015 - 2027 (USD Million)
FIG. 43 Asia Pacific male infertility market, 2015 - 2027 (USD Million)
FIG. 44 Japan male infertility market, 2015 - 2027 (USD Million)
FIG. 45 China male infertility market, 2015 - 2027 (USD Million)
FIG. 46 Latin America male infertility market, 2015 - 2027 (USD Million)
FIG. 47 Brazil male infertility market, 2015 - 2027 (USD Million)
FIG. 48 Mexico male infertility market, 2015 - 2027 (USD Million)
FIG. 49 MEA male infertility market, 2015 - 2027 (USD Million)
FIG. 50 South Africa male infertility market, 2015 - 2027 (USD Million)
FIG. 51 Strategy framework
FIG. 52 Male infertility competitive landscape: Market position analysis (based on products, regional presence, and recent updates (2019))

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ラクトフェリンの世界市場2020-2027:市場規模、シェア、動向分析(Lactoferrin Market Size, Share & Trends Analysis Report By Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial), By Application, By Region, And Segment Forecasts, 2020 - 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆